Alpha Emitter Radium-223 and Survival in Metastatic Prostate CancerChris Parker, Oliver Sartor, Joe M. O’Sullivan et al.|New England Journal of Medicine|2013Cited by 3.3k
Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trialOliver Sartor, Christopher Parker, Robert L. Coleman et al.|The Lancet Oncology|2014Cited by 491